However, two enzymes (cholesterol esterase (CEase) and pancreatic lipase (PL) have been associated with hyperlipidemia and hypercholesterolemia complications, and their inhibitory potentials have been targeted by scientists in order to develop anti-hypercholesteremic drugs [1,3]. The gene discussed is PNLIP; the disease is hyperlipidemia.